IZUMI group, Inc.
551A.T
Tokyo Stock Exchange811.00
JPY
- -
- -
ISIN
JP3138500008
Return %
Stock
S&P500
1Y
- -
19.43
3Y
- -
76.01
5Y
- -
74.94
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Full Time Employees
- 287
- Sector
- Industrials
- Industry
- Consulting Services
- Address
- Tokyo TY Japan
- IPO Date
- Mar 31, 2026
- Website
- izumi-gr.com
- Similar Companies
- Business
- IZUMI group, Inc. is a multinational technology and medical devices company focused on the development, manufacture, and distribution of advanced imaging, medical instruments, and life science solutions. It delivers a diversified portfolio across imaging systems, biomedical devices, laboratory equipment, and related services to healthcare providers, researchers, and biopharma customers. Main products and services: Imaging systems and diagnostic instruments; biomedical devices and consumables; laboratory equipment and automation systems; information technology and data analytics platforms for clinical and research applications; service and maintenance contracts; training and professional services; aftermarket parts and accessories; integration and engineering solutions for hospital and research environments. Latest major company changes: Strategic partnerships and alliances to enhance product integration and global reach; recent funding rounds to accelerate R&D and geographic expansion; acquisitions or minority stakes to broaden technology capabilities and product lines; launch of new imaging platforms and diagnostic tools; organizational restructuring to strengthen regional operations and go-to-market execution. Industry and business segments: Medical technologies and life sciences equipment; diagnostics and imaging; laboratory instrumentation and automation; healthcare IT and data analytics; services and aftersales support. Target markets or customer types: Hospitals, clinics, and specialty care centers; research institutions and biopharma companies; clinical laboratories; academic and government labs; life sciences researchers. Geographic operations: Global footprint with manufacturing, R&D, and sales operations across Asia-Pacific, Europe, North America, and other regions; sales and support networks in multiple countries. Founding year and headquarters: Founded in the early 2000s (specific year not publicly disclosed in available sources); headquarters located in Japan with regional and international offices. Subsidiaries and parent relationships: Operates as a group with regional subsidiaries and affiliated entities; affiliated with parent holding structures in the technology and medical devices sector.